Psychiatry and Neurology, Neurology · Orlando, FL
NPI
1255377099
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
92 N Dean Rd, St 100
Orlando, FL, 32825
Phone (407) 916-0304
Groups this clinician bills Medicare through
Medicare paid, 2024
$664K
50,715 services
Medicare patients, 2024
697
Average age 75
Drug cost, 2024
$949K
1,375 prescriptions
Company payments, 2025
$387K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramon L Rodriguez-Cruz was code J0585 (injection, onabotulinumtoxina, 1 unit), 43,510 times for 87 patients. In total Ramon L Rodriguez-Cruz billed 50,715 services in 50 codes, and Medicare paid $664K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-21.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 43,510 | 87 | $4.94 | $215K |
| 99214 Office E&M - Established | Office | 1,137 | 495 | $92.53 | $105K |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 609 | 76 | $59.15 | $36K |
| 99215 Office E&M - Established | Office | 603 | 330 | $130.99 | $79K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 383 | 200 | $12.74 | $4,881 |
| 96132 Behavioral Health Services | Office | 234 | 226 | $95.69 | $22K |
| 96138 Behavioral Health Services | Office | 229 | 221 | $25.05 | $5,737 |
| 95874 Musculoskeletal | Office | 187 | 74 | $56.28 | $11K |
| 99205 Office E&M - New | Office | 174 | 174 | $156.96 | $27K |
| 95819 Neurologic | Office | 170 | 169 | $324.21 | $55K |
| 96139 Behavioral Health Services | Office | 122 | 122 | $26.12 | $3,187 |
| 64616 Musculoskeletal | Office | 115 | 41 | $165.32 | $19K |
| 64612 Musculoskeletal | Office | 93 | 35 | $128.13 | $12K |
| 96116 Behavioral Health Services | Office | 81 | 80 | $70.44 | $5,705 |
| 95970 Electrical Nerve Conductivity | Office | 62 | 35 | $13.71 | $850 |
By year: 2022 $358K for 26,100 services; 2023 $607K for 40,989 services; 2024 $664K for 50,715 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramon L Rodriguez-Cruz prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 213 prescriptions and refills. In total Ramon L Rodriguez-Cruz wrote 1,375 Medicare prescriptions that cost $949K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 213 | 522 | 100 | $8,438 |
| Clonazepam Generic | 159 | 171 | 24 | $1,036 |
| Botox Onabotulinumtoxina | 87 | 260 | 36 | $112K |
| Rytary Carbidopa/Levodopa | 78 | 134 | 33 | $107K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 52 | 113 | 22 | $1,517 |
| Temazepam Generic | 44 | 44 | Under 11 | $332 |
| Quetiapine Fumarate Generic | 41 | 76 | 16 | $352 |
| Nuplazid Pimavanserin Tartrate | 37 | 41 | Under 11 | $199K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 36 | 81 | 17 | $816 |
| Rivastigmine Generic | 34 | 54 | 16 | $5,766 |
| Sertraline Hcl Generic | 29 | 74 | Under 11 | $139 |
| Alprazolam Generic | 28 | 28 | 17 | $169 |
| Donepezil Hcl Generic | 26 | 41 | 11 | $176 |
| Amantadine Amantadine Hcl | 26 | 48 | Under 11 | $2,488 |
| Gabapentin Generic | 24 | 44 | 12 | $611 |
Brand drugs: 363 claims; generic drugs: 1,012 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramon L Rodriguez-Cruz $387K ($157K in general payments such as food, travel and fees and $230K for research) from 32 companies. The largest payer was Amneal Pharmaceuticals LLC with $237K.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 14 | $237K |
| Eisai Inc. 4523.T | 57 | $42K |
| Neurocrine BioSciences, Inc. NBIX | 44 | $31K |
| MDD US Operations, LLC | 24 | $22K |
| Abbvie Inc. ABBV | 50 | $22K |
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $15K |
| Merz Pharmaceuticals, LLC | 16 | $13K |
| Tanabe Pharma America, Inc. | 7 | $4,163 |
| Pfizer Inc. PFE | 36 | $412 |
| ACADIA Pharmaceuticals Inc ACAD | 12 | $263 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.